RxDoctor Payments Data

Herman Matallana, DO

Plastic Surgery within the Head & Neck · Lakeland, FLNPI 1205982931

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 96.3% of the total across 59 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 23 manufacturers, the largest accounting for just 17.6% — the pattern of someone who eats at a lot of different presentations. That places this record below the midpoint for plastic surgery within the head & neck clinicians in FL, where the typical reported total is $1,436.

$1,421in general payments, 2019–2025

Across 59 payments — averaging $24.09 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Kaleo, Inc.$250
  • Cochlear Americas$202
  • Stryker$160
  • Sanofi$155
  • GSK$103
  • Alk-abello, Inc$68
  • plus $484 from 17 others

What the payments were for

  • Food & beverage$1,36896%
  • Education$534%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,421 in reported general payments places this provider in the 45th percentile of 50 plastic surgery within the head & neck providers in Florida.

See all plastic surgery within the head & neck providers in Florida

Medicare billing

Part B allowed, 2024
$34,205
Medicare patients
126
Services billed
464

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Arnuity ElliptaFluticasone Furoate33$6,971
Epinephrine22$5,310
Fluticasone Propionate HfaFluticasone Propionate12$3,390
Ipratropium Bromide81$2,352
Neomycin-Polymyxin-HcNeomycin/Polymyxin B/Hydrocort21$2,351
Levocetirizine Dihydrochloride173$2,073
Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav89$1,492
Ciprofloxacin-DexamethasoneCiprofloxacin Hcl/Dexameth11$1,204
Montelukast Sodium116$1,028
Azelastine Hcl58$1,026
Famotidine156$925
Fluticasone Propionate98$910
Fluocinolone Acetonide Oil24$696
Pantoprazole Sodium107$605
Ofloxacin12$231

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
GSKArnuity Ellipta$103$6,97133 claims
Hikma Pharmaceuticals USAEpinephrine$33$5,31022 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 45th percentile of 50 plastic surgery within the head & neck providers in Florida.

Other plastic surgery within the head & neck in Lakeland

See the full list for Florida

Where these figures come from

Is this you, or does something look wrong? →